A Study of E6742 in Participants With Systemic Lupus Erythematosus

NCT07515014 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

256

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: E6742
OTHER: Placebo

Sponsor

Eisai Co., Ltd.